EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Feasibility of patient-reported outcomes collection in clinical routine at a radiotherapy department

Ingrid Fagerström Kristensen iD, Anton Linnér, Martin Nilsson, Viktor Rogowski, Per Munck Af Rosenschöld iD, Mats Jerkeman iD

Acta Oncologica · 22.04.2026 · 65 · 326-332

DOI: 10.2340/ao.v65.45546 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Oncologica, online erschienen am 22.04.2026. Verfasst von Ingrid Fagerström Kristensen und 5 weiteren Autor:innen. Beteiligte Einrichtung: Oncology, Lund University, SE-221 85 Lund, Sweden; Radiation physics, Department of Hematology, Oncology and Radiation Physics, Skåne University Hosp…. Hauptthemen laut MEDLINE: Patient Reported Outcome Measures, Quality of Life, Neoplasms. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and purpose: Routine collection of patient-reported outcome measures (PROMs) may provide valuable real-world data on quality of life (QoL) and treatment tolerability, complementing clinical outcomes. This study evaluated the feasibility of launching a semi-automated, department-wide PROM collection program at a large tertiary radiotherapy centre.Patients and methods: Patients ≥ 18 years referred for radiotherapy were invited to participate. Exclusion criteria were inability to provide informed consent, severe cognitive conditions, or language barriers. PROMs were collected using a web-based application (“Blå Appen”) at baseline, end-of-treatment, and follow-up intervals, using the EORTC QLQ-C30 questionnaire (Version 3).

Results

During the study period (January 2022 to April 2025), 12,472 patients underwent treatment in the department. A total of 4,764 provided informed consent for study participation, where 3,699 (77.6%) remained after exclusion due to data loss or data inconsistency. Among these, 3,056 patients (82.6%) provided at least one usable PROM questionnaire at baseline. Participants were younger (median age 69 years vs. 71 years). Overall, global health status was relatively high at baseline and remained stable or slightly improved at one-year follow-up. To further investigate clinically significant changes in QoL over time, we evaluated the proportion of patients in each diagnostic category who experienced a change of > 10 points in selected QLQ-C30 scales between baseline and follow-up. Breast cancer patients had the highest rates of meaningful improvement and the lowest rates of major deterioration. In contrast, prostate cancer patients were more prone to significant declines in QoL scales over time.

Interpretation

This prospective study demonstrates that department-wide collection of PROM is feasible. Using a digital platform, we achieved a high initial response rate and successfully engaged patients across a broad range of cancers. The routine PROM collection provided valuable insights into patients’ quality of life and symptom burden during and after treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Patient Reported Outcome MeasuresQuality of LifeNeoplasmsHumansFemaleAgedMaleFeasibility StudiesMiddle AgedAdultSurveys and QuestionnairesAged, 80 and overFollow-Up Studies

Autor:innen und Institutionen

  • Oncology, Lund University, SE-221 85 Lund, Sweden; Radiation physics, Department of Hematology, Oncology and Radiation Physics, Skåne University Hospital, Sweden, SE-221 85 Lund, Sweden.
  • Radiation physics, Department of Hematology, Oncology and Radiation Physics, Skåne University Hospital, Sweden, SE-221 85 Lund, Sweden.
  • Oncology, Department of Hematology, Oncology and Radiation Physics, Skåne University Hospital, Skane University Hospital, SE-221 85 Lund, Sweden; Oncology, Lund University, SE-221 85 Lund, Sweden.
  • Medical Radiation Physics, Lund University, SE-221 85 Lund, Sweden; Radiation physics, Department of Hematology, Oncology and Radiation Physics, Skåne University Hospital, Sweden, SE-221 85 Lund, Sweden.
  • Oncology, Department of Hematology, Oncology and Radiation Physics, Skåne University Hospital, Skane University Hospital, SE-221 85 Lund, Sweden; Oncology, Lund University, SE-221 85 Lund, Sweden. mats.jerkeman@med.lu.s…

ORCID-Profile: Ingrid Fagerström Kristensen, Per Munck Af Rosenschöld, Mats Jerkeman

Zitieren

APA

Fagerström Kristensen, I., Linnér, A., Nilsson, M., Rogowski, V., Munck Af Rosenschöld, P., & Jerkeman, M. (2026). Feasibility of patient-reported outcomes collection in clinical routine at a radiotherapy department. Acta Oncologica, 65, 326-332. https://doi.org/10.2340/ao.v65.45546

Vancouver

Fagerström Kristensen I, Linnér A, Nilsson M, Rogowski V, Munck Af Rosenschöld P, Jerkeman M. Feasibility of patient-reported outcomes collection in clinical routine at a radiotherapy department. Acta Oncologica. 2026;65:326-332. doi:10.2340/ao.v65.45546

BibTeX
@article{FagerstrmKristensen2026,
  author = {Fagerström Kristensen, Ingrid and Linnér, Anton and Nilsson, Martin and Rogowski, Viktor and Munck Af Rosenschöld, Per and Jerkeman, Mats},
  title = {Feasibility of patient-reported outcomes collection in clinical routine at a radiotherapy department},
  journal = {Acta Oncologica},
  year = {2026},
  volume = {65},
  pages = {326--332},
  doi = {10.2340/ao.v65.45546}
}
Kostenlos starten →